기사 (31건) 리스트형 웹진형 타일형 Q3 clinical trial approvals hit 250, down 40% from Q2 Q3 clinical trial approvals hit 250, down 40% from Q2 HanAll Biopharma, JW, Daewon Pharmaceutical, and Daewoong increase foreign ownership in Q3 HanAll Biopharma, JW, Daewon Pharmaceutical, and Daewoong increase foreign ownership in Q3 Daewoong Bio ranks first in third-quarter drug approvals Daewoong Bio ranks first in third-quarter drug approvals EvrysdiㆍVabysmo get new insurance coverage, more benefits for Spinraza EvrysdiㆍVabysmo get new insurance coverage, more benefits for Spinraza Sunil Verma, Senior Vice President and Global Head of Oncology, Medical, at AstraZeneca Sunil Verma, Senior Vice President and Global Head of Oncology, Medical, at AstraZeneca Koselugo gains committee approval, Tagrisso coverage expands [Newsmp] South Korea's Drug Reimbursement Evaluation Co... 132 drugs from 72 pharmas get MFDS nod in August 132 drugs from 72 pharmas get MFDS nod in August EnvlometㆍNexviazymeㆍVerquvoㆍNgenla enter South Korea’s national health insurance EnvlometㆍNexviazymeㆍVerquvoㆍNgenla enter South Korea’s national health insurance Big Pharma shows polarization in oncology division Big Pharma shows polarization in oncology division Big Pharma struggles in the face of the endemic, but Lilly and Novo Nordisk thrive Big Pharma struggles in the face of the endemic, but Lilly and Novo Nordisk thrive TrulicityㆍOzempicㆍWegovyㆍMounjaro sales boom TrulicityㆍOzempicㆍWegovyㆍMounjaro sales boom Next-generation cancer drugs advance, SMA treatments stagnate Next-generation cancer drugs advance, SMA treatments stagnate 처음처음이전이전123끝끝